New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination

Rebecca A Clark, Chathika K Weerasuriya, Allison Portnoy, Christinah Mukandavire, Matthew Quaife, Roel Bakker, Danny Scarponi, Rebecca C Harris, Kirankumar Rade, Sanjay Kumar Mattoo, Dheeraj Tumu, Nicolas A Menzies, Richard G White
doi: https://doi.org/10.1101/2023.02.24.23286406

Data Availability

Epidemiologic data used are available from the World Health Organization Global TB Report CSV files to download (https://www.who.int/teams/global-tuberculosis-programme/data) and summarised in the Supplementary Material. Population estimates and projections are available from the United Nations Department of Economic and Social Affairs World Population Prospects 2019 (https://population.un.org/wpp/Download/Standard/Population/). Analytic code will be made available at https://doi.org/10.5281/zenodo.6421372 immediately following publication indefinitely for anyone who wishes to access the data for any purpose.

Back to top
Posted February 24, 2023.
Download PDF

Supplementary Material

Data/Code
Email
New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination
Rebecca A Clark, Chathika K Weerasuriya, Allison Portnoy, Christinah Mukandavire, Matthew Quaife, Roel Bakker, Danny Scarponi, Rebecca C Harris, Kirankumar Rade, Sanjay Kumar Mattoo, Dheeraj Tumu, Nicolas A Menzies, Richard G White
medRxiv 2023.02.24.23286406; doi: https://doi.org/10.1101/2023.02.24.23286406
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area